Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on August 4, 2025
CORA Physical Therapy Opens New Clinic Inside LA Fitness in Lakewood Ranch, Florida
CORA expands to 127 Florida clinics with new Lakewood Ranch location inside LA Fitness, offering accessible, expert physical therapy care. LAKEWOOD RANCH, FL, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- CORA Physical Therapy is proud to announce …
Holistic Practitioners Turn to Red Light Therapy to Meet Rising Demand for Non-Invasive Healing Tools
From integrative chiropractors to functional nutritionists, an increasing number of practitioners are incorporating red light therapy into their practices CLEARWATER, FL, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- The global red light therapy …
Coach Cass Wraps 30-Day Africa Journey with Transformational Women’s Retreat Across Tanzania and Zanzibar
Coach Cass Wraps 30-Day Africa Journey with Transformational Women’s Retreat Across Tanzania and Zanzibar FORT LAUDERDALE, FL, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- Relationship coach and global women’s empowerment leader Dr. Casandra “ …
CodaPet launches compassionate in-home pet euthanasia services in Orlando, FL
The veterinarian-owned startup empowers a network of veterinarians who provide in-home euthanasia to ease the passing of pets at home, surrounded by loved ones. ORLANDO, FL, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- CodaPet has officially …
Atlantic Health Strategies and Care Predictor Partnership Aims to Improve Hiring Outcomes in Behavioral Health
Strategic collaboration integrates predictive hiring technology into Atlantic’s HR Managed Services to improve clinical outcomes through better staff alignment. WEST PALM BEACH, FL, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- Atlantic Health …
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a …
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers …
WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) reschedules its earnings release and conference call for the quarterly period ended June 30, 2025, to finalize its Fresh Start …
Regional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for Merger
Atlanta, GA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that, at special meetings of their …
Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
EDEN PRAIRIE, Minn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 8, 2025, …
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it issued grants of employment inducement awards to Anshul Thakral, the Company’s recently …
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the …
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
-CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells collected across all regions; positioning the program for strong future growth- -Clinical trial ongoing for …